UK

New breast cancer drug given green light for NHS use

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.

Patients in England with a form of breast cancer will be offered a new treatment
Patients in England with a form of breast cancer will be offered a new treatment (Rui Vieira/PA)
By Ella Pickover, PA Health Correspondent